The Center for AI and Robotic Excellence in Medicine (CARE) is designed to advance AI and robotics for medical research, ...
The FDA cleared the investigational new drug (IND) application for a global phase 3 registrational trial of iSCIB1+, a DNA ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...
Infinitopes, a clinical-stage cancer vaccine biotechnology company, today announced the successful completion of the second close of its seed financing round, securing an additional $15.4 million and ...
The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...
Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results